18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.

Source:http://linkedlifedata.com/resource/pubmed/id/20847160

Download in:

View as

General Info

PMID
20847160